Royce & Associates’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-551
| Closed | -$37K | – | 1216 |
|
|
2019
Q3 | $37K | Sell |
551
-1,132
| -67% | -$76K | ﹤0.01% | 1085 |
|
|
2019
Q2 | $98K | Buy |
1,683
+126
| +8% | +$7.34K | ﹤0.01% | 1013 |
|
|
2019
Q1 | $109K | Buy |
1,557
+84
| +6% | +$5.88K | ﹤0.01% | 1016 |
|
|
2018
Q4 | $95K | Buy |
1,473
+273
| +23% | +$17.6K | ﹤0.01% | 1003 |
|
|
2018
Q3 | $84K | Hold |
1,200
| – | – | ﹤0.01% | 1037 |
|
|
2018
Q2 | $60K | Hold |
1,200
| – | – | ﹤0.01% | 1080 |
|
|
2018
Q1 | $38K | Hold |
1,200
| – | – | ﹤0.01% | 1110 |
|
|
2017
Q4 | $41K | Hold |
1,200
| – | – | ﹤0.01% | 1108 |
|
|
2017
Q3 | $39K | Hold |
1,200
| – | – | ﹤0.01% | 1094 |
|
|
2017
Q2 | $39K | Hold |
1,200
| – | – | ﹤0.01% | 1105 |
|
|
2017
Q1 | $38K | Hold |
1,200
| – | – | ﹤0.01% | 1108 |
|
|
2016
Q4 | $35K | Sell |
1,200
-67,300
| -98% | -$1.96M | ﹤0.01% | 1074 |
|
|
2016
Q3 | $1.98M | Sell |
68,500
-20,000
| -23% | -$578K | 0.01% | 805 |
|
|
2016
Q2 | $2.29M | Buy |
88,500
+12,000
| +16% | +$311K | 0.02% | 784 |
|
|
2016
Q1 | $1.9M | Buy |
76,500
+10,000
| +15% | +$248K | 0.01% | 836 |
|
|
2015
Q4 | $2.34M | Buy |
66,500
+31,500
| +90% | +$1.11M | 0.01% | 818 |
|
|
2015
Q3 | $741K | Buy |
35,000
+2,000
| +6% | +$42.3K | ﹤0.01% | 1001 |
|
|
2015
Q2 | $917K | Hold |
33,000
| – | – | ﹤0.01% | 1037 |
|
|
2015
Q1 | $1.01M | Hold |
33,000
| – | – | ﹤0.01% | 1019 |
|
|
2014
Q4 | $1.06M | Hold |
33,000
| – | – | ﹤0.01% | 1064 |
|
|
2014
Q3 | $934K | Hold |
33,000
| – | – | ﹤0.01% | 1138 |
|
|
2014
Q2 | $904K | Hold |
33,000
| – | – | ﹤0.01% | 1158 |
|
|
2014
Q1 | $869K | Hold |
33,000
| – | – | ﹤0.01% | 1167 |
|
|
2013
Q4 | $966K | Hold |
33,000
| – | – | ﹤0.01% | 1175 |
|
|
2013
Q3 | $1.01M | Hold |
33,000
| – | – | ﹤0.01% | 1172 |
|
|
2013
Q2 | $1.05M | Buy |
+33,000
| New | +$1.05M | ﹤0.01% | 1159 |
|